Uremic Toxin Removal With a New High Flux Cellulose Triacetate Membrane

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00230906

Enrollment

Registered

2005-10-03

Start date

2001-01-31

Completion date

2002-04-30

Last updated

2007-12-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Haemodialysis

Brief summary

Comparison of the uremic toxin removal by haemodialysis either with a low flux or a new high flux cellulose triacetate membrane

Detailed description

Comparison of the uremic toxin removal by haemodialysis either with a low flux or a new high flux cellulose triacetate membrane

Interventions

PROCEDUREHaemodialysis with either low or high flux membranes

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Chronic haemodialysis patient * Serum albumin \> 3.6 g/dl

Exclusion criteria

* \< 18 years

Design outcomes

Primary

Measure	Time frame
Concentration of uremic components after 3 weeks of haemodialysis	—

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026